Anti-Pancreatic Cancer Drug Development Based on Enhancing FasL-Induced Apoptosis and Evaluation Mechanisms and Combined Benefits with Chemotherapy Agents/Radiation Treatment

Project title

以增進FasL引起的細胞凋亡為考量的抗胰臟癌天然藥物研發並評估與化療藥物/放射線療法合併之應用及機轉探討

Internal ID

NSC97-2320-B002-019-MY3

Principal Investigator

Start Date

August 1, 2009

End Date

July 31, 2010

Organizations

Partner Organizations

National Science and Technology Council